当前位置： SCI文献检索 > Diabetes & Vascular Disease Research期刊下所有文献 > Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.

Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.

Abstract：

OBJECTIVES:Assess the effect of risk factors changes on risk for cardiovascular disease and mortality in patients with type 2 diabetes selected from the Swedish National Diabetes Register. METHODS:Observational study of 13,477 females and males aged 30-75 years, with baseline HbA1c 41-67 mmol/mol, systolic blood pressure 122-154 mmHg and ratio non-HDL:HDL 1.7-4.1, followed for mean 6.5 years until 2012. Four groups were created: a reference group (n = 6757) with increasing final versus baseline HbA1c, systolic blood pressure and non-HDL:HDL cholesterol during the study period, and three groups with decreasing HbA1c (n = 1925), HbA1c and systolic blood pressure (n = 2050) or HbA1c and systolic blood pressure and non-HDL:HDL (n = 2745). RESULTS:Relative risk reduction for fatal/nonfatal cardiovascular disease was 35% with decrease in HbA1c only (mean 6 to final 49 mmol/mol), 56% with decrease in HbA1c and systolic blood pressure (mean 12 to final 128 mmHg) and 75% with combined decreases in HbA1c, systolic blood pressure and non-HDL:HDL (mean 0.8 to final 2.1), all p < 0.001 adjusting for clinical characteristics, other risk factors, treatments and previous cardiovascular disease. Similar risk reductions were found for fatal/nonfatal coronary heart disease, fatal cardiovascular disease, all-cause mortality and also in a subgroup of 3038 patients with albuminuria. CONCLUSION:Considerable risk reductions for cardiovascular disease and mortality were seen with combined long-term risk factor improvement.

journal_name

Diab Vasc Dis Res

journal_title

Diabetes & vascular disease research

authors

Eeg-Olofsson K,Zethelius B,Gudbjörnsdottir S,Eliasson B,Svensson AM,Cederholm J

doi

10.1177/1479164116637311

subject

Has Abstract

pub_date

2016-07-01 00:00:00

pages

268-77

issue

4

eissn

1479-1641

issn

1752-8984

pii

1479164116637311

journal_volume

13

pub_type

杂志文章

相关文献

Diabetes & Vascular Disease Research文献大全
  • Insulin resistance and cardiovascular disease risk factors in subjects with prehypertension.

    abstract：:Prehypertension is considered to be associated with increased cardiovascular disease (CVD), and some data suggest that insulin resistance is common in this group. The goal of this study was to quantify insulin action by determining the steady-state plasma glucose (SSPG) concentration during the insulin suppression tes...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164110396919

    authors： Knobler H,Abbasi F,Lamendola C,Reaven GM

    更新日期：2011-01-01 00:00:00

  • Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs?

    abstract：:Roux-en-Y bypass surgery is increasingly used for treatment of gross obesity due to the general inability of lifestyle change and existing drug treatments to counter the obesity epidemic. This common form of bariatric surgery involves bypass of the small intestine with significant reduction of body of weight that is i...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.3132/dvdr.2007.034

    authors： Flatt PR

    更新日期：2007-06-01 00:00:00

  • Variability of clopidogrel response in patients with type 2 diabetes mellitus.

    abstract：:The global prevalence of diabetes mellitus (DM) continues to climb, and is accompanied by an increase in DM associated complications, most often manifesting as coronary heart disease. Platelet dysfunction has been implicated as a central contributor to the increased risk of coronary artery disease in patients with DM,...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,评审

    doi：10.1177/1479164111420890

    authors： Hall HM,Banerjee S,McGuire DK

    更新日期：2011-10-01 00:00:00

  • Non-LDL-related dyslipidaemia and coronary risk: a case-control study.

    abstract：:To assess the non-LDL-C-related dyslipidaemia risk of MI, 823 men aged 23 to 65 with a first MI were compared with 823 MI-free PROCAM controls matched for sex, age, smoking, DM, BP and LDL-C. Overall, the odds of MI in men with HDL-C < 1.15 mmol/L were 2.6 times those of men with HDL-C >or= 1.15 mmol/L, and the odds o...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164110372640

    authors： Assmann G,Cullen P,Schulte H

    更新日期：2010-07-01 00:00:00

  • Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy.

    abstract：:The aim of this study was to evaluate changes in lipid profiles in patients with type 2 diabetes after treatment conversion from rosiglitazone to pioglitazone while maintaining stable statin and other lipid-altering therapies. A total of 305 patients were enrolled in this open-label study. Patients had been taking sta...

    journal_title：Diabetes & vascular disease research

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.3132/dvdr.2006.005

    authors： Berhanu P,Kipnes MS,Khan MA,Perez AT,Kupfer SF,Spanheimer RC,Demissie S,Fleck PR

    更新日期：2006-05-01 00:00:00

  • Effects of sodium glucose co-transporter 2 inhibitors on the kidney.

    abstract：:Sodium-glucose cotransporter 2 inhibitors are antihyperglycaemic medications with an emerging evidence base for cardiovascular and kidney disease risk reduction. Sodium-glucose cotransporter 2 inhibitors medications lower plasma glucose by inhibiting glucose reabsorption in the proximal tubule of the kidney independen...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,评审

    doi：10.1177/1479164118783756

    authors： de Albuquerque Rocha N,Neeland IJ,McCullough PA,Toto RD,McGuire DK

    更新日期：2018-09-01 00:00:00

  • Ethnic differences in beta-cell function, dietary intake and expression of the metabolic syndrome among UK adults of South Asian, black African-Caribbean and white-European origin at high risk of metabolic syndrome.

    abstract：:A cross-sectional analysis of ethnic differences in dietary intake, insulin sensitivity and beta-cell function, using the intravenous glucose tolerance test (IVGTT), was conducted on 497 healthy adult participants of the 'Reading, Imperial, Surrey, Cambridge, and Kings' (RISCK) study. Insulin sensitivity (Si) was sign...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164112467545

    authors： Goff LM,Griffin BA,Lovegrove JA,Sanders TA,Jebb SA,Bluck LJ,Frost GS,RISCK Study Group.

    更新日期：2013-07-01 00:00:00

  • Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia.

    abstract：:Cardiovascular disease is the leading cause of morbidity and mortality in subjects with type 2 diabetes mellitus. Increased aortic stiffness, assessed with the carotid-femoral pulse wave velocity, is an independent risk factor for cardiovascular disease. Statins reduce effectively cardiovascular disease and mortality ...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164118805320

    authors： Grigoropoulou P,Tentolouris A,Eleftheriadou I,Tsilingiris D,Vlachopoulos C,Sykara M,Tentolouris N

    更新日期：2019-01-01 00:00:00

  • Relationship between leisure-time physical activity and metabolic syndrome using varying definitions: 1999-2004 NHANES.

    abstract：PURPOSE:To examine the relationship between leisure-time physical activity (LTPA) and the metabolic syndrome in the U.S. adult population. METHODS:The sample (N=5,620) in this cross-sectional study included adults aged 20 years and older. Physical activity was measured in two ways: a six-level measure based upon those...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164109336040

    authors： Churilla JR,Fitzhugh EC

    更新日期：2009-04-01 00:00:00

  • Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome.

    abstract：BACKGROUND AND OBJECTIVES:The risk of major adverse cardiac and cerebrovascular events following acute coronary syndrome is increased in people with diabetes. Predicting out-of-hospital outcomes upon follow-up remains difficult, and no simple, well-validated tools exist for this population at present. We aim to evaluat...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,多中心研究

    doi：10.1177/1479164119892137

    authors： Baluja A,Rodríguez-Mañero M,Cordero A,Kreidieh B,Iglesias-Alvarez D,García-Acuña JM,Martínez-Gómez A,Agra-Bermejo R,Alvarez-Rodríguez L,Abou-Jokh C,López-Ratón M,Gude-Sampedro F,Alvarez-Escudero J,González-Juanatey JR

    更新日期：2020-01-01 00:00:00

  • Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions.

    abstract：BACKGROUND:C-type lectin receptors, including Dectin-2, are pattern recognition receptors on monocytes and macrophages that mainly recognize sugars and sugar-like structures present on fungi. Activation of C-type lectin receptors induces downstream CARD9 signalling, leading to the production of cytokines. We hypothesiz...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164119892140

    authors： Thiem K,Hoeke G,Zhou E,Hijmans A,Houben T,Boels MG,Mol IM,Lutgens E,Shiri-Sverdlov R,Bussink J,Kanneganti TD,Boon MR,Stienstra R,Tack CJ,Rensen PC,Netea MG,Berbée JF,van Diepen JA

    更新日期：2020-01-01 00:00:00

  • Diabetes-induced early molecular and functional changes in aortic heart valves in a murine model of atherosclerosis.

    abstract：:Diabetes contributes directly to the development of cardiovascular aortic valve disease. There is currently no drug therapy available for a dysfunctional valve and this urges the need for additional research to identify distinctive mechanisms of cardiovascular aortic valve disease evolution. The aim of this study was ...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164119874469

    authors： Tucureanu MM,Filippi A,Alexandru N,Ana Constantinescu C,Ciortan L,Macarie R,Vadana M,Voicu G,Frunza S,Nistor D,Simionescu A,Simionescu DT,Georgescu A,Manduteanu I

    更新日期：2019-11-01 00:00:00

  • The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).

    abstract：:The objective of this study was to evaluate the safety and tolerability of atorvastatin 10 mg compared with placebo in 2,838 patients with type 2 diabetes and no history of coronary heart disease who were enrolled in the Collaborative Atorvastatin Diabetes Study (CARDS) and followed for 3.9 years. The percentages of p...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.3132/dvdr.2008.029

    authors： Newman CB,Szarek M,Colhoun HM,Betteridge DJ,Durrington PN,Hitman GA,Neil HA,Demicco DA,Auster S,Fuller JH,Cards Investigators.

    更新日期：2008-09-01 00:00:00

  • Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.

    abstract：OBJECTIVE:To characterize copeptin levels and to explore its prognostic importance in patients with acute myocardial infarction with newly detected glucose abnormalities. METHODS:Copeptin was measured in 166 patients with acute myocardial infarction without known diabetes and in 168 age- and gender-matched controls. P...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,多中心研究

    doi：10.1177/1479164116664490

    authors： Smaradottir MI,Ritsinger V,Gyberg V,Norhammar A,Näsman P,Mellbin LG

    更新日期：2017-03-01 00:00:00

  • Physical activity for the prevention and management of youth-onset type 2 diabetes mellitus: focus on cardiovascular complications.

    abstract：:With the growing prevalence of childhood obesity and type 2 diabetes mellitus (T2DM) in youth, the challenge of cardiovascular disease risk management has entered the paediatric realm, affecting specialists, family physicians and allied healthcare professionals alike. Currently, there is little evidence to support opt...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,评审

    doi：10.3132/dvdr.2007.057

    authors： McGavock J,Sellers E,Dean H

    更新日期：2007-12-01 00:00:00

  • Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study.

    abstract：:Antidiabetic thiazolidinediones (TZDs) improve endothelial function in patients with or without type 2 diabetes. The present randomised, placebo-controlled, double-blind study examined the time course of a single dose of rosiglitazone on flow-mediated endothelium-dependent vasodilation (FMD), metabolic parameters, and...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,随机对照试验

    doi：10.1177/1479164110367812

    authors： Walcher T,Walcher D,Hetzel J,Mielke C,Rau M,Rittig K,Balletshofer B,Schwedhelm E,Hombach V,Böger RH,Koenig W,Marx N

    更新日期：2010-07-01 00:00:00

  • Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls.

    abstract：OBJECTIVES:Coronary atherosclerosis in patients with type 2 diabetes mellitus may be promoted by regional fat distribution. We investigated the association between anthropometric measures of obesity, truncal fat mass, epicardial adipose tissue and coronary atherosclerosis in asymptomatic patients and matched controls. ...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164119825761

    authors： Gullaksen S,Funck KL,Laugesen E,Hansen TK,Dey D,Poulsen PL

    更新日期：2019-07-01 00:00:00

  • The importance of low serum levels of high-density lipoprotein cholesterol (HDL-C) as a cardiovascular risk factor.

    abstract：:In order to discuss and establish a joint position on the treatment of low serum levels of high-density lipoprotein cholesterol (HDL-C), a group of experts involved in the care of people with dyslipidaemia and at risk of cardiovascular disease met in Miami, Florida, U.S., on 5th and 6th March 2005. The experts came fr...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,实务指引

    doi：10.3132/dvdr.2005.016

    authors： Espinosa-Larrañaga F,Vejar-Jalaf M,Medina-Santillán R,Latin American Group.

    更新日期：2005-10-01 00:00:00

  • Atherosclerosis in type 2 diabetes: a role for fibrate therapy?

    abstract：:Vascular complications associated with type 2 diabetes confer significant morbidity and mortality. Atherosclerosis develops much earlier and progresses more rapidly than in subjects without diabetes. The clustering of cardiovascular risk factors associated with type 2 diabetes is mainly responsible for accelerated ath...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,评审

    doi：10.3132/dvdr.2007.067

    authors： Steiner G

    更新日期：2007-12-01 00:00:00

  • Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome.

    abstract：:Metabolic syndrome (MetS) is a clustering of atherosclerotic coronary heart disease risk factors. This post-hoc analysis compared the effects of switching to ezetimibe/simvastatin 10/20 mg or rosuvastatin 10 mg in a cohort of 618 high-risk hypercholesterolaemic patients with (n=368) and without (n=217) MetS who had pr...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1177/1479164111418136

    authors： Averna M,Missault L,Vaverkova H,Farnier M,Viigimaa M,Dong Q,Shah A,Johnson-Levonas AO,Taggart W,Brudi P

    更新日期：2011-10-01 00:00:00

  • Insulin resistance: The linchpin between prediabetes and cardiovascular disease.

    abstract：:The aim of this study was to test the hypothesis that cardiovascular disease occurs to the greatest extent in persons with prediabetes mellitus who are also insulin resistant. In 2003, 664 non-diabetic women (n = 457) and men (n = 207), aged 52 ± 16 and 53 ± 15 years, were surveyed during a programme for cardiovascula...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164115610057

    authors： Salazar MR,Carbajal HA,Espeche WG,Aizpurúa M,Leiva Sisnieguez CE,Leiva Sisnieguez BC,Stavile RN,March CE,Reaven GM

    更新日期：2016-03-01 00:00:00

  • The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO).

    abstract：:Telmisartan partially activates the peroxisome proliferator-activated receptor γ (PPARγ), which may ameliorate the accumulation of visceral adipose tissues and sensitise insulin action. Nineteen patients with essential hypertension and metabolic syndrome were randomly assigned to receive 40 mg of telmisartan (TELMI gr...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,随机对照试验

    doi：10.1177/1479164112444640

    authors： Murakami K,Wada J,Ogawa D,Horiguchi CS,Miyoshi T,Sasaki M,Uchida HA,Nakamura Y,Makino H

    更新日期：2013-01-01 00:00:00

  • Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey.

    abstract：AIM:We examined eligibility and preventable cardiovascular disease events in US adults with diabetes mellitus from the Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). METHODS:We identified adults with diabetes mellitus eligible for EMPA-REG OUTCOME based on tri...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164120945674

    authors： Wong ND,Fan W,Pak J

    更新日期：2020-07-01 00:00:00

  • Impaired response to exercise intervention in the vasculature in metabolic syndrome.

    abstract：:Physical activity decreases risk for diabetes and cardiovascular disease morbidity and mortality; however, the specific impact of exercise on the diabetic vasculature is unexamined. We hypothesized that an acute, moderate exercise intervention in diabetic and hypertensive rats would induce mitochondrial biogenesis and...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164112459664

    authors： Knaub LA,McCune S,Chicco AJ,Miller M,Moore RL,Birdsey N,Lloyd MI,Villarreal J,Keller AC,Watson PA,Reusch JE

    更新日期：2013-05-01 00:00:00

  • Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention.

    abstract：:There are few data concerning the relationship between diabetes mellitus, the metabolic syndrome and inflammation following elective percutaneous coronary intervention (PCI). The purpose of this study was to assess basal and peak levels of candidate cytokines in 40 patients undergoing elective PCI. Patients were categ...

    journal_title：Diabetes & vascular disease research

    pub_type： 临床试验,杂志文章

    doi：10.3132/dvdr.2005.003

    authors： Marso SP,Murphy JW,House JA,Safley DM,Harris WS

    更新日期：2005-02-01 00:00:00

  • Respond to the letter on 'Interobserver reliability of the ankle brachial index, toe-brachial index and distal pulse palpation in patients with diabetes: a methodological issue'.

    abstract：:We respond to the letter of Nadery and Shahsavari regarding our paper entitled 'Interobserver reliability of the ankle brachial index, toe -brachial index and distal pulse palpation in patients with diabetes. In this letter, we concluded that despite some limitations, the kappa coefficient is an informative measure of...

    journal_title：Diabetes & vascular disease research

    pub_type： 评论,信件

    doi：10.1177/1479164118794901

    authors： Álvaro Afonso FJ,García-Morales E,Molines-Barroso RJ,García-Álvarez Y,Sanz-Corbalán I,Lázaro-Martínez JL

    更新日期：2018-11-01 00:00:00

  • Metabolic syndrome, aging, physical inactivity, and incidence of type 2 diabetes in general African population.

    abstract：:The first objective of this study was to determine the baseline prevalence of metabolic syndrome and its individual components using the NCEP-R/ATPIII criteria, IDF criteria for Europe, and IDF criteria for Africa: waist circumference of at least 94 cm for men and women. The second objective was to investigate the inc...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164109346362

    authors： Longo-Mbenza B,On'kin JB,Okwe AN,Kabangu NK,Fuele SM

    更新日期：2010-01-01 00:00:00

  • RAGE and its ligands: a lasting memory in diabetic complications?

    abstract：:The complications of diabetes are myriad and represent a rising cause of morbidity and mortality, particularly in the Western world. The update of the Diabetes Control and Clinical Trials Group/Epidemiology of Diabetes Interventions and Complications Research Group (DCCT/EDIC) suggested that previous strict control of...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章,评审

    doi：10.3132/dvdr.2004.001

    authors： Yan SF,Ramasamy R,Bucciarelli LG,Wendt T,Lee LK,Hudson BI,Stern DM,Lalla E,DU Yan S,Rong LL,Naka Y,Schmidt AM

    更新日期：2004-05-01 00:00:00

  • Long non-coding RNA nuclear paraspeckle assembly transcript 1 inhibits the apoptosis of retina Müller cells after diabetic retinopathy through regulating miR-497/brain-derived neurotrophic factor axis.

    abstract：BACKGROUND:The role of long non-coding RNA in diabetic retinopathy, a serious complication of diabetes mellitus, has attracted increasing attention in recent years. The purpose of this study was to explore whether long non-coding RNA nuclear paraspeckle assembly transcript 1 was involved in the context of diabetic reti...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.1177/1479164117749382

    authors： Li XJ

    更新日期：2018-05-01 00:00:00

  • Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin.

    abstract：:Adiponectin circulates in plasma as various isoforms. However, the biological activity of each isoform has not been firmly established. High molecular weight (HMW) adiponectin may be the active form of adiponectin, while a proteolytic cleavage product of adiponectin, known as globular adiponectin (gAd), has recently b...

    journal_title：Diabetes & vascular disease research

    pub_type： 杂志文章

    doi：10.3132/dvdr.2008.020

    authors： Tomizawa A,Hattori Y,Kasai K,Nakano Y

    更新日期：2008-06-01 00:00:00